Michael P Bastner Sandrini

Title: Michael P Bastner Sandrini: Innovator in Fusion Proteins

Introduction

Michael P Bastner Sandrini is a notable inventor based in Bagsvaerd, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of fusion proteins. His innovative work has led to the creation of a patent that holds promise for medical applications.

Latest Patents

Michael P Bastner Sandrini holds a patent for "MIC-1 fusion proteins and uses thereof." This invention relates to MIC-1 fusion proteins, specifically compounds that comprise fusion proteins with a MIC-1 protein or an analog at the C-terminus and a functional variant of human serum albumin at the N-terminus, connected via a peptide linker. The compounds exhibit MIC-1 activity and are associated with pharmaceutical compositions that include these compounds along with pharmaceutically acceptable excipients. The medical uses of these compounds further enhance their significance in therapeutic applications.

Career Highlights

Michael is currently associated with Novo Nordisk A/S, a leading global healthcare company. His role at Novo Nordisk allows him to contribute to advancements in medical science and biotechnology. His work is characterized by a commitment to innovation and improving patient outcomes through scientific research.

Collaborations

Michael has collaborated with esteemed colleagues such as Allan Christian Shaw and Charlotte Helgstrand. These collaborations have fostered a productive environment for research and development, leading to advancements in their respective fields.

Conclusion

Michael P Bastner Sandrini is a distinguished inventor whose work in fusion proteins has the potential to impact the medical field significantly. His contributions through patents and collaborations reflect his dedication to innovation and scientific progress.